

Bloomberg Surveillance TV: March 28, 2024
Mar 28, 2024
Guests Matthew Miskin, Steve Center, and Robert Davis discuss market dependency on a dovish Fed, EV production outlook, and Merck's new lung disease drug. Topics include managing market expectations, Powell's financial policy approach, electric vehicle transition challenges, competition in the auto industry, innovative drug approval for pulmonary arterial hypertension, and drug pricing in healthcare.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Navigating Communication Challenges Amidst Economic Uncertainties
01:32 • 8min
Exploration of Powell's Approach to Financial Policy Amidst Market Challenges
09:47 • 2min
Transitioning to Electric Vehicles: Challenges and Opportunities
12:12 • 8min
Exploring the Value of Competition and Transparency in the Auto Industry
20:32 • 3min
Innovative Drug Approval for Pulmonary Arterial Hypertension
23:05 • 4min
Patient Outcomes, Drug Pricing, and Innovation in Healthcare
26:46 • 3min